| A STING-activating nanovaccine for cancer immunotherapy M Luo, H Wang, Z Wang, H Cai, Z Lu, Y Li, M Du, G Huang, C Wang, ... Nature nanotechnology 12 (7), 648-654, 2017 | 764 | 2017 |
| Uterine neoplasms, version 1.2023, NCCN clinical practice guidelines in oncology N Abu-Rustum, C Yashar, R Arend, E Barber, K Bradley, R Brooks, ... Journal of the National Comprehensive Cancer Network 21 (2), 181-209, 2023 | 157 | 2023 |
| NCCN Guidelines® insights: uterine neoplasms, version 3.2021: featured updates to the NCCN guidelines NR Abu-Rustum, CM Yashar, K Bradley, SM Campos, J Chino, HS Chon, ... Journal of the National Comprehensive Cancer Network 19 (8), 888-895, 2021 | 130 | 2021 |
| Detection of phosphatidylserine-positive exosomes as a diagnostic marker for ovarian malignancies: a proof of concept study J Lea, R Sharma, F Yang, H Zhu, ES Ward, AJ Schroit Oncotarget 8 (9), 14395, 2017 | 98 | 2017 |
| Radiotherapy versus inguinofemoral lymphadenectomy as treatment for vulvar cancer patients with micrometastases in the sentinel node: results of GROINSS-V II MHM Oonk, B Slomovitz, PJW Baldwin, HC Van Doorn, J Van der Velden, ... Journal of Clinical Oncology 39 (32), 3623-3632, 2021 | 93 | 2021 |
| LKB1 loss promotes endometrial cancer progression via CCL2-dependent macrophage recruitment CG Peña, Y Nakada, HD Saatcioglu, GM Aloisio, I Cuevas, S Zhang, ... The Journal of clinical investigation 125 (11), 4063-4076, 2015 | 92 | 2015 |
| Adenosquamous histology predicts poor outcome in low-risk stage IB1 cervical adenocarcinoma JS Lea, RL Coleman, EO Garner, LR Duska, DS Miller, JO Schorge Gynecologic oncology 91 (3), 558-562, 2003 | 87 | 2003 |
| Complete groin lymphadenectomy with preservation of the fascia lata in the treatment of vulvar carcinoma JG Bell, JS Lea, GC Reid Gynecologic oncology 77 (2), 314-318, 2000 | 87 | 2000 |
| Cervical cancer JS Lea, KY Lin Obstetrics and Gynecology Clinics 39 (2), 233-253, 2012 | 85 | 2012 |
| A phase II trial of stereotactic ablative radiation therapy as a boost for locally advanced cervical cancer K Albuquerque, V Tumati, J Lea, C Ahn, D Richardson, D Miller, ... International Journal of Radiation Oncology* Biology* Physics 106 (3), 464-471, 2020 | 80 | 2020 |
| Adjuvant gemcitabine plus docetaxel followed by doxorubicin versus observation for high-grade uterine leiomyosarcoma: a phase III NRG oncology/gynecologic oncology group study ML Hensley, D Enserro, H Hatcher, PB Ottevanger, A Krarup-Hansen, ... Journal of Clinical Oncology 36 (33), 3324-3330, 2018 | 80 | 2018 |
| Endocervical curettage at conization to predict residual cervical adenocarcinoma in situ JS Lea, CH Shin, EE Sheets, RL Coleman, PA Gehrig, LR Duska, ... Gynecologic oncology 87 (1), 129-132, 2002 | 80 | 2002 |
| Oxygenation in cervical cancer and normal uterine cervix assessed using blood oxygenation level‐dependent (BOLD) MRI at 3T RR Hallac, Y Ding, Q Yuan, RW McColl, J Lea, RD Sims, PT Weatherall, ... NMR in biomedicine 25 (12), 1321-1330, 2012 | 77 | 2012 |
| Stage IIB–IVB cervical adenocarcinoma: prognostic factors and survival JS Lea, EE Sheets, RM Wenham, LR Duska, RL Coleman, DS Miller, ... Gynecologic oncology 84 (1), 115-119, 2002 | 77 | 2002 |
| Synergistic STING activation by PC7A nanovaccine and ionizing radiation improves cancer immunotherapy M Luo, Z Liu, X Zhang, C Han, LZ Samandi, C Dong, BD Sumer, J Lea, ... Journal of Controlled Release 300, 154-160, 2019 | 75 | 2019 |
| Aberrant p16 methylation is a biomarker for tobacco exposure in cervical squamous cell carcinogenesis JS Lea, R Coleman, A Kurien, JO Schorge, DS Miller, JD Minna, ... American journal of obstetrics and gynecology 190 (3), 674-679, 2004 | 72 | 2004 |
| P16 as a molecular biomarker of cervical adenocarcinoma JO Schorge, JS Lea, KJ Elias, R Rajanbabu, RL Coleman, DS Miller, ... American journal of obstetrics and gynecology 190 (3), 668-673, 2004 | 71 | 2004 |
| A phase I-II evaluation of veliparib (NSC# 737664), topotecan, and filgrastim or pegfilgrastim in the treatment of persistent or recurrent carcinoma of the uterine cervix: an … C Kunos, W Deng, D Dawson, JS Lea, KM Zanotti, HJ Gray, DP Bender, ... International Journal of Gynecologic Cancer 25 (3), 2015 | 68 | 2015 |
| Silencing of HPV 18 oncoproteins With RNA interference causes growth inhibition of cervical cancer cells JS Lea, N Sunaga, M Sato, G Kalahasti, DS Miller, JD Minna, CY Muller Reproductive sciences 14, 20-28, 2007 | 68 | 2007 |
| De novo prediction of cancer-associated T cell receptors for noninvasive cancer detection D Beshnova, J Ye, O Onabolu, B Moon, W Zheng, YX Fu, J Brugarolas, ... Science translational medicine 12 (557), eaaz3738, 2020 | 67 | 2020 |
David Scott MillerUniversity of Texas Southwestern Medical Center在 UTSouthwestern.edu 的电子邮件经过验证
